DMCFX | FSMAX | DMCFX / FSMAX | |
Total Expense Ratio | 0.74 | 0.04 | 2,114% |
Annual Report Gross Expense Ratio | 0.74 | 0.04 | 2,114% |
Fund Existence | 6 years | 14 years | - |
Gain YTD | 3.719 | 8.572 | 43% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.27B | 39.6B | 16% |
Annual Yield % from dividends | 0.00 | 0.46 | - |
Returns for 1 year | 6.91 | 15.48 | 45% |
Returns for 3 years | 28.75 | 46.63 | 62% |
Returns for 5 years | 9.68 | 53.91 | 18% |
Returns for 10 years | N/A | 98.43 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EQIDX | 13.76 | 0.02 | +0.15% |
Allspring Emerging Markets Eq Advtg Adm | |||
HLHIX | 27.66 | N/A | N/A |
Virtus KAR Health Sciences Inst | |||
VFWAX | 43.65 | N/A | N/A |
Vanguard FTSE All-Wld ex-US Idx Admiral | |||
TSCWX | 19.95 | N/A | N/A |
Nuveen Quant Small Cap Equity W | |||
ARTSX | 35.88 | -0.51 | -1.40% |
Artisan Small Cap Investor |